current affair

Bharat Biotech's COVAXIN, through an efficacy analysis, demonstrated to be 77.8% effective against the symptomatic COVID-19, through an evaluation of 130 confirmed cases, with 24 being observed in a vaccine group versus 106 in the placebo group.

from Jagran Josh https://ift.tt/3hfVUTr
via IFTTT